Back

Genotype or phenotype or both? Current risk prediction in dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy

30 August 2026 (18:00 - 18:15)
Organised by: Logo
Congress Presentation Part of: Personalised risk stratification in cardiomyopathies: where are we now? Risk Factors and Risk Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Lia Crotti

University of Milan Bicocca, Milan (Italy)

3 More presentations in this session

Presentation thumbnail
What is the current role of cardiac magnetic resonance and clinical risk scores in risk stratification for hypertrophic cardiomyopathy?
Professor P. Elliott (London, GB)
Slides Video
Presentation thumbnail
Is the arrhythmogenic right ventricular cardiomyopathy phenotype outdated for risk prediction?
Doctor A. te Riele (Utrecht, NL)
Slides Video
Presentation thumbnail
Personalised risk stratification in cardiomyopathies: where are we now? - discussion
Video

Access the full session

Session thumbnail
Personalised risk stratification in cardiomyopathies: where are we now?
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 18:00 CET
You may be interested in
thumbnail
Congress Presentation
'The overlooked middle': patient with non-ischaemic cardiomyopathy and moderately impaired ejection fraction
12 April 2026
thumbnail
Congress Presentation
The “negative” side of cardiomyopathy: phenotype and arrhythmic risk in gene-elusive patients
28 August 2026
thumbnail
Congress Presentation
State-of-the-art lecture on cutting-edge science in dilated cardiomyopathy
29 August 2026
thumbnail
Congress Presentation
Genotype-driven prognostication in dilated cardiomyopathy
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources